Mongolia vs New Caledonia: The number of people with susceptibility test result for rifampicin
Mongolia
100
in 2021
New Caledonia
100
in 2021
Mongolia rank
2nd
New Caledonia rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Mongolia
- New Caledonia
How they compare
Mongolia currently reports 100 against 100 in New Caledonia, a difference of 0.
Across all 5 years both countries report, New Caledonia has been ahead every year.
Mongolia ranks 2nd and New Caledonia ranks 2nd of 146 countries.
New Caledonia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mongolia | New Caledonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 74.64 | 100 | 25.36 | New Caledonia |
| 2020s | 100 | 100 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Mongolia or New Caledonia?
- Mongolia, at 100 against 100 in New Caledonia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Mongolia and New Caledonia?
- 0, with Mongolia ahead.
- How many years of comparable data are there for Mongolia and New Caledonia?
- 5 years are reported by both, from 2017 to 2021.
- How do Mongolia and New Caledonia rank globally for the number of people with susceptibility test result for rifampicin?
- Mongolia ranks 2nd and New Caledonia ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.